Please assess the completion status of the following clinical trial:

Trial Title: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Early and advanced Idiopathic Parkinson Disease with early morning motor impairment~Exclusion Criteria:~* Atypical Parkinsonian syndromes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rotigotine (Type: EXPERIMENTAL): Rotigotine transdermal patch
- Placebo (Type: PLACEBO_COMPARATOR): Placebo transdermal patch

Based on this trial design, predict the completion outcome and termination type (if applicable).